US2019343093A1PendingUtilityA1
Humanized il-7 rodents
Est. expiryJun 18, 2032(~5.9 yrs left)· nominal 20-yr term from priority
Inventors:Andrew J. Murphy
A01K 67/0278A01K 2217/052A01K 2207/15C07K 14/5418A01K 2217/07A01K 2217/072A01K 2267/0393A01K 2267/0331A01K 2267/0387A01K 2267/03A01K 2267/01A01K 2227/105C12N 15/09
70
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Genetically modified non-human animals comprising a human or humanized interleukin-7 (IL-7) gene. Cells, embryos, and non-human animals comprising a human or humanized IL-7 gene. Rodents that express human or humanized IL-7 protein. Genetically modified mice that comprise a human or humanized IL-7-encoding gene in their germline, wherein the human or humanized IL-7-encoding gene is under control of endogenous mouse IL-7 regulatory sequences.
Claims
exact text as granted — not AI-modified1 . An isolated cell obtained from a genetically modified rodent,
wherein the genome of the cell and the genome of the rodent comprise a humanized IL-7 gene, wherein the humanized IL-7 gene comprises exons 2, 3, 4, 5, and 6 of a human IL-7 gene, and is operably linked to endogenous rodent IL-7 5′ regulatory sequences, wherein the human IL-7 gene comprises the nucleotide sequence of SEQ ID NO: 3, wherein the rodent is a mouse or a rat, and wherein the IL-7 protein encoded by the humanized IL-7 gene is expressed in the serum of the rodent.
2 . The cell of claim 1 , wherein the humanized IL-7 gene is at an endogenous rodent IL-7 locus and comprises (i) exon 1 of an endogenous rodent IL-7 gene, and (ii) exons 2, 3, 4, 5, and 6 of the human IL-7 gene, and wherein the rodent IL-7 locus comprising the humanized IL-7 gene lacks rodent IL-7 exons 2, 3, 4, and 5.
3 . The cell of claim 1 , wherein the humanized IL-7 gene comprises exon 1 of an endogenous rodent IL-7 gene, and exons 2, 3, 4, 5, and 6 of the human IL-7 gene.
4 . The cell of claim 1 , wherein the rodent is a rat.
5 . The cell of claim 1 , wherein the rodent is a mouse.
6 . An isolated tissue obtained from a genetically modified rodent,
wherein the genome of the cells in the tissue and the genome of the rodent comprise a humanized IL-7 gene, wherein the humanized IL-7 gene comprises exons 2, 3, 4, 5, and 6 of a human IL-7 gene, and is operably linked to endogenous rodent IL-7 5′ regulatory sequences, wherein the human IL-7 gene comprises the nucleotide sequence of SEQ ID NO: 3, wherein the rodent is a mouse or a rat, and wherein the IL-7 protein encoded by the humanized IL-7 gene is expressed in the serum of the rodent.
7 . The tissue of claim 6 , wherein the humanized IL-7 gene is at an endogenous rodent IL-7 locus and comprises (i) exon 1 of an endogenous rodent IL-7 gene, and (ii) exons 2, 3, 4, 5, and 6 of the human gene, and wherein the rodent IL-7 locus comprising the humanized IL-7 gene lacks rodent IL-7 exons 2, 3, 4, and 5.
8 . The tissue of claim 6 , wherein the humanized IL-7 gene comprises exon 1 of an endogenous rodent IL-7 gene, and exons 2, 3, 4, 5, and 6 of the human IL-7 gene.
9 . The tissue of claim 6 , wherein the rodent is a rat.
10 . The tissue of claim 6 , wherein the rodent is a mouse.
11 . An isolated rodent embryonic stem (ES) cell whose genome comprises a humanized IL-7 gene,
wherein the humanized IL-7 gene comprises exons 2, 3, 4, 5, and 6 of a human IL-7 gene, and is operably linked to endogenous rodent IL-7 5′ regulatory sequences, wherein the human IL-7 gene comprises the nucleotide sequence of SEQ ID NO: 3, wherein the embryonic stem cells generates a rodent whose genome comprises said humanized IL-7 gene, wherein the rodent is a mouse or a rat and expresses the IL-7 protein encoded by the humanized IL-7 gene in the serum.
12 . The ES cell of claim 11 , wherein the humanized IL-7 gene is at an endogenous rodent IL-7 locus and comprises (i) exon 1 of an endogenous rodent IL-7 gene, and (ii) exons 2, 3, 4, 5, and 6 of the human IL-7 gene, and wherein the rodent IL-7 locus comprising the humanized IL-7 gene lacks rodent IL-7 exons 2, 3, 4, and 5.
13 . The ES cell of claim 11 , wherein the humanized IL-7 gene comprises exon 1 of an endogenous rodent IL-7 gene, and exons 2, 3, 4, 5, and 6 of the human IL-7 gene.
14 . The ES cell of claim 11 , wherein the rodent is a rat.
15 . The ES cell of claim 11 , wherein the rodent is a mouse.
16 . A rodent embryo comprising the rodent ES cell of claim 11 .
17 . The rodent embryo of claim 16 , wherein the humanized IL-7 gene is at an endogenous rodent IL-7 locus and comprises (i) exon 1 of an endogenous rodent IL-7 gene, and (ii) exons 2, 3, 4, 5, and 6 of the human IL-7 gene, and wherein the rodent IL-7 locus comprising the humanized IL-7 gene lacks rodent IL-7 exons 2, 3, 4, and 5.
18 . The rodent embryo of claim 16 , wherein the humanized IL-7 gene comprises exon 1 of an endogenous rodent IL-7 gene, and exons 2, 3, 4, 5, and 6 of the human IL-7 gene.
19 . The rodent embryo of claim 16 , wherein the rodent embryo is a rat embryo.
20 . The rodent embryo of claim 16 , wherein the rodent embryo is a mouse embryo.Join the waitlist — get patent alerts
Track US2019343093A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.